Artelus AI model that can be used to reduce the burden on the healthcare workforce for reading chest X-Ray for pneumonia & COVID-19
As per a Mckinsey article "the length of disruption for patients continuing physical distancing remains unclear".
Introducing World's First Contactless Artificial Intelligence (AI) powered Diabetic Retinopathy Screening. Touch free fundus eye examination in less than 3 minutes.
We have developed an early diagnostic AI solution that is accurate, affordable and easily accessible for screening, diagnosing and preventing communicable and non communicable diseases. Our award winning AI on a chip plug and play solution and first of its kind contact less remote screening solution can be seamlessly integrated to health offering in any setting.
If you are a healthcare organization looking forward to materially scale virtual health offerings that creates a competitive advantage contact us for a demo of our virtual screening product.
DRISTi is our unique patent applied technology designed to analyse the prevelence of diabetic retinopathy.
Read More
Patent applied proprietary technology that segregates between a bad image and a good image.
Read More
Sahastra is a system that brings together Institutions, Annotators, Doctors and Patients together on a single platform.
Read More
Our team is working on developing primary screening tools to detect TB, Breast cancer and Lung cancer. We are also working in diagnostic solutions that would assist the doctors in accurate diagnosis for faster treatment by providing a comprehensive reporting of anomalies detected during primary screening process.
Our products offer primary screening solutions for problems that are inevitably going to strike, and preempt them from getting worse. Identifying people with diseases at early stage can help them avoid disease complications and expensive treatments.
View All
